APX-115 (Synonyms: Ewha-18278) |
Catalog No.GC38353 |
APX-115 (Ewha-18278) es un potente inhibidor de pan NADPH oxidasa (Nox) activo por vÍa oral con valores de Ki de 1,08 μM, 0,57 μM y 0,63 μM para Nox1, Nox2 y Nox4, respectivamente.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1395946-75-4
Sample solution is provided at 25 µL, 10mM.
APX-115 (Ewha-18278) is a potent, orally active pan NADPH oxidase (Nox) inhibitor with Ki values of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 effectively prevents kidney injury[1].
[1]. Kwon G, et al. A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis. Oncotarget. 2017 Jun 16;8(43):74217-74232.
Average Rating: 5
(Based on Reviews and 22 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *